Emerg Infect Dis by Guerrero, Manuel L. Fernandez et al.
LETTERS
B. microti has been transmitted
through blood transfusion in Connec-
ticut (8).  Blood collection agencies in
southwestern Connecticut and adja-
cent Westchester County, New York,
should be aware of the possibility that
blood donors could be infected with
this pathogen. Physicians should also
be alert to the possibility that patients
could be coinfected with the etiologic
agents of Lyme disease or human
granulocytic ehrlichiosis. Some
patients in whom Lyme disease was
diagnosed have been simultaneously
infected with B. microti (9,10).
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Migratory
Thrombophlebitis
and Acute Q Fever
To the Editor: Q fever is a world-
wide zoonosis particularly common in
some cattle- raising countries such as
Great Britain, France, Spain,
Australia, and Canada (1). Wide-
spread use of diagnostic serologic
tests has led to increasing recognition
of the disease in many other parts of
the world. For example, Q fever has
been recently described in Southeast
Asia (2).
Acute Q fever usually manifests as
a febrile syndrome with hepatic
abnormalities or pneumonia; chronic
Q fever is commonly associated with
endocarditis (3,4). When the disease
manifests with an atypical clinical
picture, diagnosis becomes difficult. 
We describe a patient in whom
Trousseau’s syndrome developed as
the sole manifestation of acute Q
fever. To the best of our knowledge,
this complication has not been found
previously in patients with Q fever.
A 39-year-old, previously healthy
man was admitted to the hospital
because of fever and subcutaneous
painful induration in the legs and
arms. Ten days previously, he had
fever, generalized aches, and malaise.
Forty-eight hours after the onset of
these symptoms, he noticed a painful
induration and redness along the right
calf that spontaneously subsided in a
few days. He remained febrile, and
additional swollen, painful indurated
lesions appeared on his thighs and
arms. Pleuritic chest pain developed,
and he was taken to the emergency
room.
On admission, he was febrile
(38.7°C). A tender, indurated cord, 10
cm long, was felt on the greater
saphenous vein of the right thigh. The
cephalic vein of the left arm and the
basilic vein of the right arm were also
tender and indurated. 
The leukocyte count was
9,800/mm3; hemoglobin 14.5 g/dL,
and platelets 441,000/mm3. The fib-
rinogen levels (385 mg/dL) and pro-
thrombin time (12 s, control 10–14 s)
were normal. The partial thrombo-
plastin time (40 s, control 26–36 s)
was mildly prolonged. Serum aspar-
tate aminotransferase was 75 U/L,
serum alanine aminotransferase was
110 UL, and γ-glutamyltranspeptidase
was 230 U/L. Antibodies to phospho-
lipids (aPL) measured by enzyme-
linked immunosorbent assay were
positive (titer of 95 for antibodies of
class IgG/titer of 19 for antibodies of
class IgM. Results of testing for
tumor-associated antigens, such as
carcinoembryonic antigen, carcinoma
antigen 19-9, prostatic specific anti-
546 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 3, March 2004
LETTERS
gen, and alpha fetoprotein, were neg-
ative. The x-ray films of the chest and
computed tomography scan of the
thorax and abdomen were normal.
The patient was treated with subcuta-
neous heparin and diclophenac, and
fever and migratory thrombophlebitis
subsided. 
Because the patient had been
working with manure several days
before his initial symptoms, Q fever
serologic testing was requested. The
antibody levels measured by comple-
ment fixation (CF) against phase II
Coxiella burnetii antigen was 1:512.
By indirect immunofluorescence, the
titers of IgM and IgG against phase I
and II were 1:64 and 1:512 and 1:256
and >2,048, respectively. Antibody
titers against Mycoplasma, Chla-
mydia, Legionella, enterovirus, and
influenza were negative.
Recovery was uneventful and the
patient was asymptomatic during a
follow-up visit 3 weeks later.
Antiphospholipid antibodies were
negative. Three months after the acute
phase of the infection, new titers of
antibodies (CF) against C. burnetii
were 1:128. Two years after the
episode the patient was asymptomatic.
This patient is unique in that he
had acute Q fever with migratory
thrombophlebitis. A diagnosis of
Trousseau’s syndrome associated with
an occult malignancy was considered
on admission, but it was excluded
soon. The recent history of exposure
to manure was the key for the clinical
diagnosis. Although specific anti-cox-
iella treatment was not given, the
patient followed a self-limited course,
and both clinical and laboratory
abnormalities promptly subsided.
Microscopic vasculitis and throm-
bosis are commonly found in patients
with other rickettsial infections (5),
but vascular phenomena must be con-
sidered an exceptional event in
patients with Q fever. However,
thrombophlebitis and pulmonary
embolisms have been occasionally
reported (6–8). These unusual mani-
festations have been associated with
aPL during the course of acute Q
fever (7,8). 
Antibodies to phospholipids have
been found in 80% of patients in a
large series of acute Q fever (9). None
of the patients in the study showed
thrombotic events or cardiac valve
involvement in contrast to patients
with lupus or primary aPL syndrome
in whom clinical manifestations
attributed to aPL developed (9). This
observation could be explained by the
fact that aPL found in patients with
lupus and primary aPL syndrome are
directed against a complex antigen
that includes a lipid-binding inhibitor
of coagulation, which has been char-
acterized as a β2-glycoprotein I
(apolipoprotein H). This glycoprotein
seems to inhibit the activation of the
contact phase system of the intrinsic
pathway of blood coagulation (10).
On the other hand, apolipoprotein H is
not necessary for the aPL activity
observed in patients with Q fever and
other infectious diseases (10).
According to these studies, the
observation of low titers of aPL in the
serum of our patient during the acute
phase of Q fever must be seen as a
finding of uncertain importance not
necessarily associated with migratory
thrombophlebitis. In short, migratory
thrombophlebitis (Trousseau’s syn-
drome) should be added to the ever-
growing list of unusual manifestations
of Q fever.
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West Nile
Poliomyelitis
To the Editor: In the July 2003
article, “Acute Flaccid Paralysis and
West Nile Virus Infection” (1), Sejvar
et al. reported seven patients with
acute onset of asymmetric weakness
and areflexia but no sensory abnor-
malities. The authors also referenced
three previously reported cases of
West Nile virus (WNV)–associated
flaccid paralysis and argued that all of
these symptoms could be explained
by anterior-horn cell loss. The two
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 3, March 2004 547
